Toggle light / dark theme

Human on a Chip

Using digital ai generated medicines plus human on a chip systems you could get new medicines out not in years but hours.


The next generation of MOC design at TissUse aims for a Human-on-a-Chip, increasing the number of interconnected organs toward acceptable organismal complexity. This number of organs is supposed to be efficient to provide human organismal homeostasis, sufficiently flexible for diverse disease modelling and to bear the potential of ultimately replacing animal models for systemic substance testing.

AI-designed drug to enter human clinical trial for first time

A drug molecule invented entirely by artificial intelligence is set to enter human clinical trials for the first time, marking a critical milestone for the role of machine learning in medicine.

The new compound, which has been designed to treat patients with obsessive-compulsive disorder, was developed by Oxford-based AI start-up Exscientia in collaboration with the Japanese pharmaceutical firm Sumitomo Dainippon Pharma.

In a sharp acceleration of the typical path to drug development, which can take about four and a half years, the AI-designed compound reached the point of entering clinical trials within just 12 months.

‘There’s no doubt’: Top US infectious disease doctor says Wuhan coronavirus can spread even when people have no symptoms

People without ANY symptoms can spread Wuhan Coronavirus.


The nation’s top infectious disease doctor says a new study published Thursday night shows people can spread the Wuhan coronavirus before symptoms set in.

German researchers found that the virus was transmitted by people without symptoms in five instances in one cluster of people: from a parent to a daughter; from that daughter to two colleagues; and from one of those colleagues to two other coworkers.

Preventing metastasis

Olivier Feron, a University of Louvain researcher, studies how cancer spreads through the body via metastasis. His major discovery was that cancer cells multiply by using lipids as food. His latest discovery, published in the scientific journal Nature Communications, is that lipid storage promotes cancer invasiveness. A new drug currently being tested to treat obesity may also help fight metastasis.

Rare clay used by B.C. aboriginals found to kill antibiotic-resistant bacteria

VANCOUVER — Researchers at the University of British Columbia have confirmed that a rare clay used as medicine by aboriginals in B.C. contains antibacterial properties that could be used to to treat antibiotic-resistant bacteria.

Some 400 kilometres north of Vancouver, on the Heiltsuk First Nation’s traditional territory, sits a 400-million kilogram deposit of glacial clay in Kisameet Bay that scientists believe was formed near the end of the last Ice Age, approximately 10,000 years ago.

The grey-green clay, known as Kisolite, has been used for centuries by the Heiltsuk First Nations to treat a range of ailments including ulcerative colitis, arthritis, neuritis, phlebitis, skin irritation, and burns. Locals also use the clay for eczema, acne and psoriasis.

Genomics and BioPharma Pioneer!! — Dr. William Haseltine — Biologist, entrepreneur and philanthropist, now focusing on the issues of healthcare costs, dementia care, and aging — ideaXme — Ira Pastor

From Blood to Bone (and Back)! — Dr. Rhonda Prisby — University of Texas, Arlington — Fascinating ossification research in the Bone Vascular and Micro-Circulation Laboratory — ideaXme — Ira Pastor